Dr. Alpdogan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 S 11th St
Philadelphia, PA 19107Phone+1 215-955-6000Fax+1 215-955-8549
Summary
- Dr. S. Onder Alpdogan is an oncologist in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. He received his medical degree from Hacettepe University Faculty of Medicine and has been in practice 33 years. He also speaks multiple languages, including Turkish. He specializes in hematologic oncology and is experienced in immunotherapy, bone marrow transplantation, B-cell lymphomas, T-cell lymphomas, and Hodgkin Lymphoma.
Clinical Expertise
- Hematologic Cancers, Bone marrow transplantation, Immunotherapy, T-cell lymphomas, Lymphoma, B-cell lymphomas, Hodgkin's lymphoma, Medical oncology, Ophthalmic oncology, Pediatric hematology / oncology, Complex medical dermatology
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
- Memorial Sloan Kettering Cancer CenterFellowship, Transplant Immunology, 2000 - 2003
- Marmara University HospitalFellowship, Hematology, 1992 - 1995
- Hacettepe University FOMClass of 1983
Certifications & Licensure
- NJ State Medical License 2019 - 2025
- PA State Medical License 2009 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Publications & Presentations
PubMed
- 7 citationsResponse to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study.Emily Correia, Shalini Krishnasamy, Jayson G Suriano, Wenyin Shi, Seyfettin Onder Alpdogan
Clinical Lymphoma, Myeloma & Leukemia. 2022-08-01 - 143 citationsAdoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.Johannes L. Zakrzewski, Adam A. Kochman, Sydney X. Lu, Theis H. Terwey, Theo D. Kim
Nature Medicine. 2006-08-27 - 24 citationsHematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma.Juliet Fraser Gibson, Onder Alpdogan, Antonio Subtil, Michael Girardi, Lynn D. Wilson
Journal of the American Academy of Dermatology. 2015-06-01
Authored Content
- SOHO 2021: Advances in Peripheral T Cell Lymphoma (PTCL) TreatmentSeptember 2021
Professional Memberships
- Member
- Member
- American Society Blood and Marrow TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: